Literature DB >> 1461283

Primary structure of dystrophin-related protein.

J M Tinsley1, D J Blake, A Roche, U Fairbrother, J Riss, B C Byth, A E Knight, J Kendrick-Jones, G K Suthers, D R Love.   

Abstract

Dystrophin-related protein (DRP or 'utrophin') is localized in normal adult muscle primarily at the neuromuscular junction. In the absence of dystrophin in Duchenne muscular dystrophy (DMD) patients, DRP is also present in the sarcolemma. DRP is expressed in fetal and regenerating muscle and may play a similar role to dystrophin in early development, although it remains to be determined whether DRP can functionally replace dystrophin in adult tissue. Previously we described a 3.5-kilobase complementary DNA clone that exhibits 80 per cent homology to the C-terminal domain of dystrophin. This sequence identifies a 13-kilobase transcript that maps to human chromosome 6 (refs 2, 11). Antibodies raised against the gene product identify a polypeptide with a relative molecular mass of about 400K in all tissues examined. To investigate the relationship between DRP and dystrophin in more detail, we have cloned and sequenced the whole DRP cDNA. Homology between DRP and dystrophin extends over their entire length, suggesting that they derive from a common ancestral gene. Comparative analysis of primary sequences highlights regions of functional importance, including those that may mediate the localization of DRP and dystrophin in the muscle cell.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1461283     DOI: 10.1038/360591a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  112 in total

Review 1.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

Review 2.  Syntrophins entangled in cytoskeletal meshwork: Helping to hold it all together.

Authors:  Sahar S Bhat; Roshia Ali; Firdous A Khanday
Journal:  Cell Prolif       Date:  2018-12-04       Impact factor: 6.831

3.  Disease-causing missense mutations in actin binding domain 1 of dystrophin induce thermodynamic instability and protein aggregation.

Authors:  Davin M Henderson; Ann Lee; James M Ervasti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

4.  Effect of beta-dystroglycan processing on utrophin/Dp116 anchorage in normal and mdx mouse Schwann cell membrane.

Authors:  K Hnia; G Hugon; A Masmoudi; J Mercier; F Rivier; D Mornet
Journal:  Neuroscience       Date:  2006-06-02       Impact factor: 3.590

Review 5.  Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Authors:  Jane T Seto; Julian N Ramos; Lindsey Muir; Jeffrey S Chamberlain; Guy L Odom
Journal:  Curr Gene Ther       Date:  2012-06       Impact factor: 4.391

6.  Dp71, utrophin and beta-dystroglycan expression and distribution in PC12/L6 cell cocultures.

Authors:  Ramses Ilarraza-Lomeli; Bulmaro Cisneros-Vega; Maria de Lourdes Cervantes-Gomez; Dominique Mornet; Cecilia Montañez
Journal:  Neuroreport       Date:  2007-10-29       Impact factor: 1.837

Review 7.  [Molecular pathogenesis of muscular diseases].

Authors:  K Ohlendieck
Journal:  Naturwissenschaften       Date:  1996-12

8.  Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.

Authors:  Guy L Odom; Paul Gregorevic; James M Allen; Eric Finn; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

9.  Molecular and functional analysis of the utrophin promoter.

Authors:  C L Dennis; J M Tinsley; A E Deconinck; K E Davies
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

10.  Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin.

Authors:  K Matsumura; I Nonaka; F M Tomé; K Arahata; H Collin; F Leturcq; D Récan; J C Kaplan; M Fardeau; K P Campbell
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.